| Filed On | Filing |
|---|---|
| 15 Dec 2021 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On November 1, 2021, Akebia Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) disclosing that on and effective November 1, 2021, the Board of Directors of the Company (the “Board”) increased the Bo... |
| 20 Dec 2018 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 14 Dec 2016 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 22 Sep 2014 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As previously disclosed in the Current Report on Form 8-K filed by Akebia Therapeutics, Inc. (the “Company”) on July 17, 2014, the Company’s Board of Directors (the “Board”) elected Michael Clayman, M.D. and Maxine Gowen, Ph.D. as direct... |
| 22 Sep 2014 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As previously disclosed in the Current Report on Form 8-K filed by Akebia Therapeutics, Inc. (the “Company”) on September 15, 2014, the Company’s Board of Directors (the “Board”) elected Ronald C. Renaud, Jr. as a director. Mr. Renaud wa... |
Loading...